跳至主要内容
临床试验/EUCTR2014-001675-32-ES
EUCTR2014-001675-32-ES进行中(未招募)不适用

Aspirin versus Aspirin + ClopidogRel as Antithrombotic Treatment Following Transcatheter Aortic Valve Implantation with the Edwards Valve. A Randomized Study (the ARTE trial). - ARTE

IUCPQ0 个研究点目标入组 300 人开始时间: 2014年7月22日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients undergoing a TAVI procedure with the Edwards valve.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 280

排除标准

  • -Need for chronic anticoagulation treatment
  • -Major bleeding within the 3 months prior to the TAVI procedure
  • -Prior intracranial bleeding
  • -Drug-eluting stent implantation within the year prior to the TAVI procedure
  • -Allergy to clopidogrel and/or aspirin/acetylsalicylic acid

研究者

发起方
IUCPQ

相似试验